These final results, together with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the strategy of targeting ACKR3 as a unique way to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked disorders. Renal parenchymal illness is https://conolidine44208.post-blogs.com/46512136/conolidine-secrets